These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 8200070)
1. DNA adducts of the ubiquitous environmental contaminant cyclopenta[cd]pyrene. Beach AC; Gupta RC Carcinogenesis; 1994 May; 15(5):1065-72. PubMed ID: 8200070 [TBL] [Abstract][Full Text] [Related]
2. Cyclopenta[cd]pyrene-induced tumorigenicity, Ki-ras codon 12 mutations and DNA adducts in strain A/J mouse lung. Nesnow S; Ross JA; Nelson G; Wilson K; Roop BC; Jeffers AJ; Galati AJ; Stoner GD; Sangaiah R; Gold A Carcinogenesis; 1994 Apr; 15(4):601-6. PubMed ID: 8149468 [TBL] [Abstract][Full Text] [Related]
3. Reaction of cyclopenta[c,d]pyrene-3,4-epoxide with DNA and deoxynucleotides. Beach AC; Agarwal SC; Lambert GR; Nesnow S; Gupta RC Carcinogenesis; 1993 Apr; 14(4):767-71. PubMed ID: 8472345 [TBL] [Abstract][Full Text] [Related]
4. Interception of reactive, DNA adduct-forming metabolites present in rodent serum following carcinogen exposure: implications for use of body fluids in biomonitoring. Garg A; Beach AC; Gupta RC Teratog Carcinog Mutagen; 1993; 13(4):151-66. PubMed ID: 7903484 [TBL] [Abstract][Full Text] [Related]
5. Metabolic activation of racemic and enantiomeric trans-8, 9-dihydroxy-8,9-dihydrodibenzo[a,l]pyrene (dibenzo[def,p]chrysene) to dibenzo[a,l]pyrene-bis-dihydrodiols by induced rat liver microsomes and a recombinant human P450 1A1 system: the role of the K-region-derived metabolic intermediates in the formation of dibenzo[a,l]pyrene-DNA adducts. Nesnow S; Davis C; Padgett W; George M; Lambert G; Meyers F; Allison J; Adams L; King LC Chem Res Toxicol; 1998 Dec; 11(12):1596-607. PubMed ID: 9860506 [TBL] [Abstract][Full Text] [Related]
6. Formation of C8-modified deoxyguanosine and C8-modified deoxyadenosine as major DNA adducts from 2-nitropyrene metabolism mediated by rat and mouse liver microsomes and cytosols. Fu PP; Miller DW; Von Tungeln LS; Bryant MS; Lay JO; Huang K; Jones L; Evans FE Carcinogenesis; 1991 Apr; 12(4):609-16. PubMed ID: 2013125 [TBL] [Abstract][Full Text] [Related]
7. DNA adduction by polychlorinated biphenyls: adducts derived from hepatic microsomal activation and from synthetic metabolites. Pereg D; Robertson LW; Gupta RC Chem Biol Interact; 2002 Feb; 139(2):129-44. PubMed ID: 11823002 [TBL] [Abstract][Full Text] [Related]
8. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice. Beland FA Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702 [TBL] [Abstract][Full Text] [Related]
9. Mechanistic linkage between DNA adducts, mutations in oncogenes and tumorigenesis of carcinogenic environmental polycyclic aromatic hydrocarbons in strain A/J mice. Nesnow S; Ross JA; Stoner GD; Mass MJ Toxicology; 1995 Dec; 105(2-3):403-13. PubMed ID: 8571376 [TBL] [Abstract][Full Text] [Related]
10. DNA adduct formation by the ubiquitous environmental contaminant 3-nitrobenzanthrone in rats determined by (32)P-postlabeling. Arlt VM; Bieler CA; Mier W; Wiessler M; Schmeiser HH Int J Cancer; 2001 Aug; 93(3):450-4. PubMed ID: 11433414 [TBL] [Abstract][Full Text] [Related]
11. Structure, conformations, and repair of DNA adducts from dibenzo[a, l]pyrene: 32P-postlabeling and fluorescence studies. Jankowiak R; Ariese F; Hewer A; Luch A; Zamzow D; Hughes NC; Phillips D; Seidel A; Platt KL; Oesch F; Small GJ Chem Res Toxicol; 1998 Jun; 11(6):674-85. PubMed ID: 9625736 [TBL] [Abstract][Full Text] [Related]
12. Role of ring oxidation in the metabolic activation of 1-nitropyrene. Beland FA Res Rep Health Eff Inst; 1991 Dec; (46):1-22; discussion 23-33. PubMed ID: 1777157 [TBL] [Abstract][Full Text] [Related]
13. DNA adduct formation by secondary metabolites of cyclopenta[cd]pyrene in vitro. Hsu CH; Skipper PL; Tannenbaum SR Cancer Lett; 1999 Mar; 136(2):137-41. PubMed ID: 10355742 [TBL] [Abstract][Full Text] [Related]
14. Microsomal and peroxidase activation of 4-hydroxy-tamoxifen to form DNA adducts: comparison with DNA adducts formed in Sprague-Dawley rats treated with tamoxifen. Pathak DN; Pongracz K; Bodell WJ Carcinogenesis; 1995 Jan; 16(1):11-5. PubMed ID: 7834794 [TBL] [Abstract][Full Text] [Related]
15. 32P-postlabeling analysis of benzo[a]pyrene-DNA adducts formed in vitro and in vivo. Bodell WJ; Devanesan PD; Rogan EG; Cavalieri EL Chem Res Toxicol; 1989; 2(5):312-5. PubMed ID: 2519823 [TBL] [Abstract][Full Text] [Related]
16. Oxidative microsomal metabolism of 1-nitropyrene and DNA-binding of oxidized metabolites following nitroreduction. Djurić Z; Fifer EK; Howard PC; Beland FA Carcinogenesis; 1986 Jul; 7(7):1073-9. PubMed ID: 3755082 [TBL] [Abstract][Full Text] [Related]
17. Metabolism and activation of cyclopenta polycyclic aromatic hydrocarbons in liver tissue from rats and humans. Johnsen NM; Nyholm SH; Haug K; Scholz T; Holme JA Chem Biol Interact; 1998 Jun; 113(3):217-37. PubMed ID: 9717520 [TBL] [Abstract][Full Text] [Related]
18. Comparative 32P-postlabeling analysis of benzo[a]pyrene--DNA adducts formed in vitro upon activation of benzo[a]pyrene by human, rabbit and rodent liver microsomes. Roggeband R; Wolterbeek AP; Rutten AA; Baan RA Carcinogenesis; 1993 Sep; 14(9):1945-50. PubMed ID: 8403223 [TBL] [Abstract][Full Text] [Related]
19. Examination of microsomal cytochrome P450-catalyzed in vitro activation of o-phenylphenol to DNA binding metabolite(s) by 32P-postlabeling technique. Pathak DN; Roy D Carcinogenesis; 1992 Sep; 13(9):1593-7. PubMed ID: 1394845 [TBL] [Abstract][Full Text] [Related]
20. Human enzymes involved in the metabolic activation of the environmental contaminant 3-nitrobenzanthrone: evidence for reductive activation by human NADPH:cytochrome p450 reductase. Arlt VM; Stiborova M; Hewer A; Schmeiser HH; Phillips DH Cancer Res; 2003 Jun; 63(11):2752-61. PubMed ID: 12782579 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]